Goldman Sachs Group Inc. Reduces Stock Holdings in Pediatrix Medical Group, Inc. $MD

Key Points

• Goldman Sachs Group Inc. reduced its stake in Pediatrix Medical Group by 15.3%, owning 565,754 shares valued at approximately $8.2 million after selling 102,013 shares in the first quarter.
• Several hedge funds, such as Principal Financial Group and GAMMA Investing LLC, increased their investments in Pediatrix Medical Group, with notable growth in their positions during the same quarter.
• Pediatrix Medical Group reported $0.53 EPS for the most recent quarter, exceeding analysts' expectations, but the company's quarterly revenue declined by 7.1% year-over-year.

Goldman Sachs Group Inc. cut its position in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 15.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 565,754 shares of the company's stock after selling 102,013 shares during the period. Goldman Sachs Group Inc. owned approximately 0.66% of Pediatrix Medical Group worth $8,198,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Principal Financial Group Inc. boosted its stake in Pediatrix Medical Group by 6.2% during the first quarter. Principal Financial Group Inc. now owns 586,190 shares of the company's stock valued at $8,494,000 after buying an additional 34,266 shares during the last quarter. GAMMA Investing LLC raised its position in Pediatrix Medical Group by 219.5% during the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock valued at $37,000 after purchasing an additional 1,765 shares during the period. SG Americas Securities LLC raised its position in Pediatrix Medical Group by 194.0% during the first quarter. SG Americas Securities LLC now owns 38,405 shares of the company's stock valued at $556,000 after purchasing an additional 25,343 shares during the period. Russell Investments Group Ltd. raised its position in Pediatrix Medical Group by 2.9% during the first quarter. Russell Investments Group Ltd. now owns 219,184 shares of the company's stock valued at $3,176,000 after purchasing an additional 6,127 shares during the period. Finally, Deutsche Bank AG raised its position in Pediatrix Medical Group by 53.1% during the fourth quarter. Deutsche Bank AG now owns 74,023 shares of the company's stock valued at $971,000 after purchasing an additional 25,663 shares during the period. 97.71% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. Zacks Research upgraded Pediatrix Medical Group to a "strong-buy" rating in a research report on Monday, August 11th. Wall Street Zen downgraded Pediatrix Medical Group from a "strong-buy" rating to a "buy" rating in a research report on Saturday, September 13th. UBS Group upped their price objective on Pediatrix Medical Group from $16.00 to $16.50 and gave the company a "neutral" rating in a research report on Thursday, August 14th. Finally, Leerink Partners increased their price target on Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a "market perform" rating in a report on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $16.79.

Pediatrix Medical Group Trading Down 1.6%

MD traded down $0.27 during trading on Friday, hitting $16.32. 239,059 shares of the stock were exchanged, compared to its average volume of 750,462. The firm has a 50 day simple moving average of $14.98 and a 200 day simple moving average of $14.22. The firm has a market cap of $1.42 billion, a price-to-earnings ratio of 12.66 and a beta of 1.30. Pediatrix Medical Group, Inc. has a 1 year low of $10.39 and a 1 year high of $17.67. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.80 and a current ratio of 1.80.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, topping the consensus estimate of $0.42 by $0.11. The company had revenue of $468.84 million for the quarter, compared to the consensus estimate of $464.37 million. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.Pediatrix Medical Group's quarterly revenue was down 7.1% on a year-over-year basis. During the same period last year, the business posted $0.34 EPS. As a group, equities analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.